Search results: Sage Journals

Restricted accessCase reportFirst published April, 2015

Denosumab in hypercalcemia of malignancy: A case series

Amanda Dietzek, Kelly Connelly, Michael Cotugno [...]

Journal of Oncology Pharmacy Practice

Restricted accessReview articleFirst published May, 2017

Denosumab: Renal Safety Evaluation

Fabio Malberti, Marina Foramitti

Journal of Onco-Nephrology

Free accessResearch articleFirst published January, 2009

Denosumab for the Treatment of Postmenopausal Osteoporosis

E Michael Lewiecki

Women's Health

Free accessResearch articleFirst published July, 2006

Denosumab: A Promising Drug for the Prevention and Treatment of Osteoporosis

E Michael Lewiecki

Women's Health

Open accessReview articleFirst published 2021

Should denosumab treatment for osteoporosis be continued indefinitely?

Jane A. Noble, Malachi J. McKenna, Rachel K. Crowley

Therapeutic Advances in Endocrinology and Metabolism

Restricted accessReview articleFirst published July, 2012

Denosumab,a RANK Ligand Inhibitor,for Postmenopausal Women with Osteoporosis

Emily E Sutton, Daniel M Riche

Annals of Pharmacotherapy

Free accessReview articleFirst published October, 2009

Denosumab in postmenopausal osteoporosis: what the clinician needs to know

E. Michael Lewiecki

Therapeutic Advances in Musculoskeletal Disease

Open accessCase reportFirst published May, 2024

Denosumab-related osteonecrosis of the external auditory canal—benefit of the early surgical management

Vojtěch Peřina, Richard Salzman, Jana Treglerová

Ear,Nose & Throat Journal

Restricted accessBrief reportFirst published January, 2020

Use of denosumab to treat refractory hypercalcemia in a peritoneal dialysis patient with immobilization and tertiary hyperparathyroidism

Ryan M Pratt, Michael L West, Karthik K Tennankore

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Restricted accessResearch articleFirst published September, 2009

Denosumab in Osteoporosis and Oncology

Jill S Burkiewicz, Sarah L Scarpace, Susan P Bruce

Annals of Pharmacotherapy

Restricted accessCase reportFirst published April, 2015

Denosumab in hypercalcemia of malignancy: A case series

Amanda Dietzek, Kelly Connelly, Michael Cotugno [...]

Journal of Oncology Pharmacy Practice

Restricted accessReview articleFirst published May, 2017

Denosumab: Renal Safety Evaluation

Fabio Malberti, Marina Foramitti

Journal of Onco-Nephrology

Free accessResearch articleFirst published January, 2009

Denosumab for the Treatment of Postmenopausal Osteoporosis

E Michael Lewiecki

Women's Health

Free accessResearch articleFirst published July, 2006

Denosumab: A Promising Drug for the Prevention and Treatment of Osteoporosis

E Michael Lewiecki

Women's Health

Open accessReview articleFirst published 2021

Should denosumab treatment for osteoporosis be continued indefinitely?

Jane A. Noble, Malachi J. McKenna, Rachel K. Crowley

Therapeutic Advances in Endocrinology and Metabolism

Restricted accessReview articleFirst published July, 2012

Denosumab,a RANK Ligand Inhibitor,for Postmenopausal Women with Osteoporosis

Emily E Sutton, Daniel M Riche

Annals of Pharmacotherapy

Free accessReview articleFirst published October, 2009

Denosumab in postmenopausal osteoporosis: what the clinician needs to know

E. Michael Lewiecki

Therapeutic Advances in Musculoskeletal Disease

Open accessCase reportFirst published May, 2024

Denosumab-related osteonecrosis of the external auditory canal—benefit of the early surgical management

Vojtěch Peřina, Richard Salzman, Jana Treglerová

Ear,Nose & Throat Journal

Restricted accessBrief reportFirst published January, 2020

Use of denosumab to treat refractory hypercalcemia in a peritoneal dialysis patient with immobilization and tertiary hyperparathyroidism

Ryan M Pratt, Michael L West, Karthik K Tennankore

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Restricted accessResearch articleFirst published September, 2009

Denosumab in Osteoporosis and Oncology

Jill S Burkiewicz, Sarah L Scarpace, Susan P Bruce

Annals of Pharmacotherapy